Dipotassium;azetidin-3-ol;2-chloro-5-[[3-(3-chlorophenyl)-2-fluoro-4-methoxyphenyl]methyl]pyrimidine;1-[5-[[3-(3-chlorophenyl)-2-fluoro-4-methoxyphenyl]methyl]pyrimidin-2-yl]azetidin-3-ol;hydride;oxido formate;hydrochloride
C43H42Cl4F2K2N6O7 — CID 159941621
Data last refreshed: (MolForge compound catalog, from PubChem)
About Dipotassium;azetidin-3-ol;2-chloro-5-[[3-(3-chlorophenyl)-2-fluoro-4-methoxyphenyl]methyl]pyrimidine;1-[5-[[3-(3-chlorophenyl)-2-fluoro-4-methoxyphenyl]methyl]pyrimidin-2-yl]azetidin-3-ol;hydride;oxido formate;hydrochloride
Dipotassium;azetidin-3-ol;2-chloro-5-[[3-(3-chlorophenyl)-2-fluoro-4-methoxyphenyl]methyl]pyrimidine;1-[5-[[3-(3-chlorophenyl)-2-fluoro-4-methoxyphenyl]methyl]pyrimidin-2-yl]azetidin-3-ol;hydride;oxido formate;hydrochloride (PubChem CID 159941621) has the molecular formula C43H42Cl4F2K2N6O7 and a molecular weight of 1012.85 g/mol. Its IUPAC name is dipotassium;azetidin-3-ol;2-chloro-5-[[3-(3-chlorophenyl)-2-fluoro-4-methoxyphenyl]methyl]pyrimidine;1-[5-[[3-(3-chlorophenyl)-2-fluoro-4-methoxyphenyl]methyl]pyrimidin-2-yl]azetidin-3-ol;hydride;oxido formate;hydrochloride.
Molecular Properties
| Compound Name | Dipotassium;azetidin-3-ol;2-chloro-5-[[3-(3-chlorophenyl)-2-fluoro-4-methoxyphenyl]methyl]pyrimidine;1-[5-[[3-(3-chlorophenyl)-2-fluoro-4-methoxyphenyl]methyl]pyrimidin-2-yl]azetidin-3-ol;hydride;oxido formate;hydrochloride |
|---|---|
| PubChem CID | 159941621 |
| Molecular Formula | C43H42Cl4F2K2N6O7 |
| Molecular Weight | 1012.85 g/mol |
| Exact Mass | 1010.11 |
| IUPAC Name | dipotassium;azetidin-3-ol;2-chloro-5-[[3-(3-chlorophenyl)-2-fluoro-4-methoxyphenyl]methyl]pyrimidine;1-[5-[[3-(3-chlorophenyl)-2-fluoro-4-methoxyphenyl]methyl]pyrimidin-2-yl]azetidin-3-ol;hydride;oxido formate;hydrochloride |
| SMILES | COc1ccc(Cc2cnc(Cl)nc2)c(F)c1-c1cccc(Cl)c1.COc1ccc(Cc2cnc(N3CC(O)C3)nc2)c(F)c1-c1cccc(Cl)c1.Cl.O=CO[O-].OC1CNC1.[H-].[K+].[K+] |
| InChI | InChI=1S/C21H19ClFN3O2.C18H13Cl2FN2O.C3H7NO.CH2O3.ClH.2K.H/c1-28-18-6-5-15(20(23)19(18)14-3-2-4-16(22)8-14)7-13-9-24-21(25-10-13)26-11-17(27)12-26;1-24-15-6-5-13(7-11-9-22-18(20)23-10-11)17(21)16(15)12-3-2-4-14(19)8-12;5-3-1-4-2-3;2-1-4-3;;;;/h2-6,8-10,17,27H,7,11-12H2,1H3;2-6,8-10H,7H2,1H3;3-5H,1-2H2;1,3H;1H;;;/q;;;;;2*+1;-1/p-1 |
| InChIKey | CLROCQSIYHVFCS-UHFFFAOYSA-M |
| XLogP | 0.83 |
| TPSA | 175.11 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 64 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1012.85 |
| LogP ≤ 5 | 0.83 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 13 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'peroxide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159941621 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.